Physician profile
Joseph Graham
NPI 1578638383
$4,100.81
in general payments reported to CMS, 2019-2025
17 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,902 · 2020: $57.44 · 2021: $74.00 · 2022: $463 · 2023: $360 · 2024: $102 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,366.39 | 2019-2020 | |
| Medtronic, INC. | $344.86 | 2021-2023 | Corevalve Evolut R |
| Elutia, INC. | $305.75 | 2019-2022 | |
| Abiomed | $242.13 | 2019-2023 | Impella |
| Atricure, INC. | $202.70 | 2019-2023 | |
| Tactile Systems Technology INC | $142.07 | 2025 | Nimbl, Flexitouch Plus |
| Edwards Lifesciences Corporation | $130.28 | 2019-2023 | Mitris Resilia Mitral Valve |
| Abbott Laboratories | $102.02 | 2024 | Epic |
| Artivion, INC. | $60.38 | 2020-2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Photofix Decellularized Bovine Pericardium, Vascular |
| Astrazeneca Pharmaceuticals LP | $48.09 | 2019-2023 | Andexxa |
| Esperion Therapeutics, INC. | $47.55 | 2022 | |
| Depuy Synthes Sales INC. | $29.15 | 2021 | |
| Bard Peripheral Vascular, INC. | $21.56 | 2019 | |
| Smith+Nephew, INC. | $19.68 | 2019 | |
| Getinge USA Sales, LLC | $14.07 | 2023 | Vasoview Hemopro 2 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $12.46 | 2019 | |
| Davol INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.